IL6 and neoplasm: These studies demonstrated that EV-associated TGFβ induced IL-6 secretion in MSCs, which drove tumor progression through paracrine STAT3 activation in OS cells, suggesting that the increased IL-6 secretion we observed in response to OS EV treatment of primary LFs may be mediating this enhancement of OS cell survival and proliferation in our model.